Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

WCLC 2021 | Bringing clinical trials to communities

Melissa Johnson • 8 Jan 2021
WCLC 2021
General

Melissa Johnson, MD, Sarah Cannon Research Institute, Nashville, TN, discusses the importance of bringing clinical trials to communities and engaging with community oncologists, outlining the strategies being implemented at the Sarah Cannon research Institute. This interview was recorded via an online conference call with The Video Journal of Oncology (VJOncology).

More from Melissa Johnson

1:49
ADCs for lung cancer
Melissa Johnson • 27 Feb 2023
1:30
Cellular therapies for NSCLC
Melissa Johnson • 27 Feb 2023
3:46
Targeting IL-2 in advanced NSCLC
Melissa Johnson • 27 Feb 2023
2:42
CodeBreaK 200: sotorasib versus docetaxel in pretreated KRAS G12C-mutant NSCLC
Melissa Johnson • 15 Sep 2022

Related Videos

1:33
TranStar101: osemitamab, a novel CLDN18.2 inhibitor, in solid tumors
Yelena Janjigian • 8 Apr 2024
1:33
How can we enhance the efficacy of theranostic nanoparticles?
Debjani Pal • 8 Apr 2024
0:36
The benefits of SJPedPanel, a novel pediatric pan-cancer gene panel
Pandurang Kolekar • 8 Apr 2024
1:08
SJPedPanel: a pan-cancer gene panel for childhood cancers
Pandurang Kolekar • 8 Apr 2024
The content of VJOncology is intended for healthcare professionals